Fate Therapeutics Inc Stock Ownership - Who owns Fate Therapeutics?

Insider buying vs selling

Have Fate Therapeutics Inc insiders been buying or selling?
Edward J. Dulac IiiChief Financial Officer2023-08-184,718$2.80
Yuan XuDirector2023-08-04632$3.71
Brian T. PowlChief Commercial Officer2023-07-053,854$4.87
Edward J. Dulac IiiChief Financial Officer2023-07-055,182$4.83
Yuan XuDirector2023-06-143,460$5.58
Redmile Group LLCDirector2023-04-21256,639$6.18
Redmile Group LLCDirector2023-04-2020,000$5.99
Yuwaye ChuChief Medical Officer2023-04-182,317$6.58
Yuwaye ChuChief Medical Officer2023-04-18215$6.52
Redmile Group LLCDirector2023-04-1425,700$6.00

1 of 3

FATE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FATE insiders and whales buy or sell their stock.

FATE Shareholders

What type of owners hold Fate Therapeutics Inc stock?
Redmile Group LLC26.49%26,104,311$55.34MInsider
Redmile Group LLC13.32%13,124,427$27.82MInstitution
Blackrock Inc12.15%11,978,558$25.39MInstitution
Vanguard Group Inc11.89%11,723,374$24.85MInstitution
State Street Corp10.46%10,313,911$21.87MInstitution
Amir Nashat10.00%9,852,967$20.89MInsider
Polaris Venture Management Co V LLC9.99%9,841,933$20.86MInsider
Bellevue Group Ag4.93%4,855,779$10.29MInstitution
D E Shaw Co Inc4.67%4,599,439$9.75MInstitution
Johnson Johnson3.43%3,379,064$7.16MInstitution

1 of 3

FATE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FATE64.94%35.06%Net BuyingNet Selling
FENC3.93%96.07%Net SellingNet Buying
ALLK44.48%55.52%Net SellingNet Selling
LYRA68.02%16.86%Net Buying
TSHA21.26%42.14%Net BuyingNet Buying

Fate Therapeutics Stock Ownership FAQ

Who owns Fate Therapeutics?

Fate Therapeutics (NASDAQ: FATE) is owned by 110.43% institutional shareholders, 59.63% Fate Therapeutics insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Fate Therapeutics shareholder, owning 26.10M shares representing 26.49% of the company. Redmile Group LLC's Fate Therapeutics shares are currently valued at $50.12M.

If you're new to stock investing, here's how to buy Fate Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.